Global Agar Market Overview
In February 2023, Thermo Fisher, a global leader in offering scientific services announced the introduction of Brilliance GBS agar. It is considered as a groundbreaking tool for the detection of Group B streptococci at the time of pregnancy. By utilizing Thermo Fishers proprietary InhibigenTM technology, this innovative Agar simplifies the testing process of Agar among clinical technicians. This provide more accurate results and fast patient treatment.
The introduction of Brilliance GBS agar will help in addressing the critical need of prenatal care, as GBS will lead to serious health risk to newborns if left undetected. By providing a more efficient and reliable diagnostics solution, Thermo Fisher will aim to enhance patient outcomes and support for better-informed and clinical decision making.
The new Agar improve the sensitivity and specificity that enables healthcare professionals to quickly identify the GBS colonization and reduce the risk of complications. With the commitment of Thermo Fisher to advancing the diagnostics capabilities is evident in the development of Brilliance GBS agar.
By leveraging the cutting-edge technology and expertise, the company continues to drive innovation in the scientific community. It will ultimately contribute to improved healthcare outcomes and enhance the quality of life.
Market Growth and Trends
As per the Coherent Market Insights, the global agar market is set to soar at a CAGR of 4.67% between 2022 and 2030. In 2021, revenue stood at a valuation of US$ 276.02 Million. Increasing awareness about the health benefits of agar as it provides a range of minerals and vitamins including phosphorous, calcium, iron, and iodine will expected to drive demand for agar market.
